跳至主要内容
临床试验/NCT01651468
NCT01651468撤回不适用

Phase 1 Study of the Nutraceutical "Hemofix" Safety and Effect on the Coagulation System

Hadassah Medical Organization1 个研究点 分布在 1 个国家开始时间: 2016年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
bleeding and blood test results

研究概览

简要总结

Hemofix is a herbal formula based on traditional Jewish and far eastern medicine created to assist in wound healing and bleeding arrest. It contains herbs such as Red Clover, Liquorice, Raspberry, Ginger and more. The present study will evaluate the formula on the coagulation system.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy volunteers and volunteers with a mild bleeding disorder

排除标准

  • people with thrombophilic and cardiovascular complications,
  • people who are treated with anti-coagulants,
  • women taking birth control pills
  • people with a history hypercoagulability

研究组 & 干预措施

HEMOFIX

Experimental

3 grams a day

干预措施: HEMOFIX (Dietary Supplement)

结局指标

主要结局

bleeding and blood test results

时间窗: one year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验